Innovation Days
About
Research
Products
Investors
Careers
Agenda
fr
Press Releases
Our latest news and press releases
All
2022
2021
2020
2019
2018
2017
04
Aug
2022
16:30 E.S.T.
Cellectis Provides Business Update and Reports Financial Results for Second Quarter 2022
Read more
01
Aug
2022
16:30 E.S.T.
Cellectis Receives IND clearance for UCART20x22, its First in-house Manufactured Product Candidate for the Treatment of B-cell Malignancies
Read more
28
Jul
2022
16:30 E.S.T.
Cellectis to Report Second Quarter 2022 Financial Results
Read more
30
Jun
2022
05:00 E.S.T.
Cellectis Publishes Article in Nature Communications Unveiling Novel Immune-Evasive Universal Allogeneic CAR T-cells with Potential for Improved Persistence
Read more
28
Jun
2022
16:30 E.S.T.
Cellectis Announces the Appointment of Axel-Sven Malkomes & Dr. Donald A Bergstrom, M.D., Ph.D., to its Board of Directors
Read more
28
Jun
2022
16:05 E.S.T.
Cellectis S.A. Reports Results from Annual Shareholders’ General Meeting Held on June 28, 2022
Read more
23
May
2022
16:30 E.S.T.
Cellectis’ Annual Shareholders’ General Meeting to be Held on June 28, 2022
Read more
16
May
2022
08:30 E.S.T.
Cellectis Presents Research Data on a Novel Immune-Evasive Universal CAR T-cell at ASGCT
Read more
12
May
2022
16:30 E.S.T.
Cellectis Provides Business Update and Reports Financial Results for First Quarter 2022
Read more
05
May
2022
16:30 E.S.T.
Cellectis to Report First Quarter 2022 Financial Results
Read more
1
2
3
Next